Author: Chris Lewis

Chris Lewis is Tech Insider's Senior Equity Research analyst covering Internet and Interactive Entertainment. Prior to joining TI in 2011, Chris spent six years at Baird Capital having established the company’s Internet and Video Game research practice. Prior to Wall Street, Chris was a business analyst developing software at Chubb Corporation, and was a co-founder and CFO of Latin American career services website Detacuche.com. Chris appears frequently in the financial and industry press, including CNBC, Bloomberg, CNN, Wall Street Journal, and Financial Times, among others.
BioTech, Stock Movers

AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Shares of AstraZeneca plc (ADR)(NYSE:AZN) reached a new high in pre-market trading as Pfizer Inc.(NYSE:PFE) confirmed it has attempted to renew negotiations on a possible merger. Pfizer submitted a preliminary indication of interest to the board of directors of AstraZeneca in January 2014 regarding the possible merger. AstraZeneca declined to pursue negotiations at that time, but Pfizer contacted AstraZeneca on April 26, 2014, seeking to renew … Continue reading AstraZeneca plc (ADR)(NYSE:AZN) Shares Soar Pre-Market

Chris Lewis
Internet, Mobile

Digi International Slides 14% as Earnings Guidance Disappoints

Digi International (DGII) shares were down nearly 14% late Friday, after the networking hardware provider missed with Q2 revenue and disappointed with Q3 and full-year guidance. Its Q2 earnings did beat Street expectations. Revenue was $45.9 million for Q2 2014, compared with $48.2 million for Q2 2013. Net income was $0.7 million, or $0.03 per diluted share, in the Q2 2014 compared to $1.0 million, … Continue reading Digi International Slides 14% as Earnings Guidance Disappoints

Chris Lewis
Finance

NASDAQ recent Insider Selling: Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Apple Inc. (NASDAQ:AAPL), Comcast Corporation (NASDAQ:CMCSA)

Facebook (NASDAQ:FB) COO Sheryl Sandberg unloaded 283,334 shares of the company’s stock on the open market in a transaction dated Tuesday, April 22nd. The shares were sold at an average price of $62.87, for a total transaction of $17,813,208.58. Facebook Inc (NASDAQ:FB) stock performance was -0.80% in last session and finished the day at $60.87. Traded volume was 138.77million shares in the last session and … Continue reading NASDAQ recent Insider Selling: Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Apple Inc. (NASDAQ:AAPL), Comcast Corporation (NASDAQ:CMCSA)

Chris Lewis
Gilead Sciences GILD NASDAQ:GILD
Finance

NASDAQ Losers: Sodastream International (NASDAQ:SODA), Agios Pharmaceuticals (NASDAQ:AGIO), Penn National Gaming (NASDAQ:PENN), Susquehanna Bancshares Inc (NASDAQ:SUSQ)

SodaStream International Ltd. (NASDAQ:SODA) jumped again on Wednesday, this time by almost 11% on news that coffee giant, Starbucks Corporation (SBUX – Analyst Report) was in “advanced talks” to buy a 10% stake in the company. Sodastream International Ltd (NASDAQ:SODA) stock performance was -5.07% in last session and finished the day at $42.49. Traded volume was 3.07million shares in the last session and the average … Continue reading NASDAQ Losers: Sodastream International (NASDAQ:SODA), Agios Pharmaceuticals (NASDAQ:AGIO), Penn National Gaming (NASDAQ:PENN), Susquehanna Bancshares Inc (NASDAQ:SUSQ)

Chris Lewis
Finance

NASDAQ Gainers: Apple Inc. (NASDAQ:AAPL), Cesca Therapeutics Inc (NASDAQ:KOOL), Canadian Solar Inc. (NASDAQ:CSIQ), Cytokinetics, Inc. (NASDAQ:CYTK)

Apple Inc. (NASDAQ:AAPL) has long been a trend-setter whose hot products attract imitators, and now its recent stock split might help revive a trend from the 1990s that has all but disappeared on Wall Street. On Wednesday, the iPad maker and largest U.S. company by market value said it would do a seven-for-one split, knocking its share price down from the $500-plus level to something … Continue reading NASDAQ Gainers: Apple Inc. (NASDAQ:AAPL), Cesca Therapeutics Inc (NASDAQ:KOOL), Canadian Solar Inc. (NASDAQ:CSIQ), Cytokinetics, Inc. (NASDAQ:CYTK)

Chris Lewis